Abstract:CXCL4 promotes cardiac fibrosis through activating the TGF‐β1/Smad2/3 signaling pathway. Inhibition of CXCL4 secretion may be considered a potential therapeutic target for myocarditis treatment. Background Severe myocarditis is often accompanied by cardiac fibrosis, but the underlying mechanism has not been fully elucidated. CXCL4 is a chemokine that has been reported to have pro‐inflammatory and profibrotic functions. The exact role of CXCL4 in cardiac fibrosis remains unclear. Methods Viral myocarditis (VMC) models were induced by intraperitoneal injection of Coxsackie B Type 3 (CVB3). In vivo, CVB3 (100 TCID50) and CVB3‐AMG487 (CVB3: 100 TCID50; AMG487: 5 mg/kg) combination were administered in the VMC and VMC+AMG487 groups, respectively. Hematoxylin and eosin staining, severity score, Masson staining, and immunofluorescence staining were performed to measure myocardial morphology in VMC. Enzyme‐linked immunosorbent assay (ELISA) and quantitative reverse transcription polymerase chain reaction (qRT‐PCR) were performed to quantify inflammatory factors (IL‐1β, IL‐6, TNF‐α, and CXCL4). Aspartate aminotransferase (AST), lactate dehydrogenase (LDH), and creatine kinase‐myocardial band (CK‐MB) levels were analyzed by commercial kits. CXCL4, CXCR3B, α‐SMA, TGF‐β1, Collagen I, and Collagen III were determined by Western blot and immunofluorescence staining. Results In vivo, CVB3‐AMG487 reduced cardiac injury, α‐SMA, Collagen I and Collagen III levels, and collagen deposition in VMC+AMG487 group. Additionally, compared with VMC group, VMC+AMG group decreased the levels of inflammatory factors (IL‐1β, IL‐6, and TNF‐α). In vitro, CXCL4/CXCR3B axis activation TGF‐β1/Smad2/3 pathway promote mice cardiac fibroblasts differentiation. Conclusion CXCL4 acts as a profibrotic factor in TGF‐β1/Smad2/3 pathway‐induced cardiac fibroblast activation and ECM synthesis, and eventually progresses to cardiac fibrosis. Therefore, our findings revealed the role of CXCL4 in VMC and unveiled its underlying mechanism. CXCL4 appears to be a potential target for the treatment of VMC.

Inhibition of IL-2 inducible T-cell kinase alleviates T-cell activation and murine myocardial inflammation associated with CVB3 infection.

Remission of CVB3-induced viral myocarditis by in vivo Th2 polarization via hydrodynamics-based interleukin-4 gene transfer.

Interleukin-6 receptor inhibition modulates the immune reaction and restores titin phosphorylation in experimental myocarditis

Inhibitor of CD147 Suppresses T Cell Activation and Recruitment in CVB3-Induced Acute Viral Myocarditis

IL-33 Enhances Macrophage M2 Polarization and Protects Mice from CVB3-induced Viral Myocarditis

Gene Therapy with CCL2 (MCP-1) Mutant Protects CVB3-induced Myocarditis by Compromising Th1 Polarization.

Inhibition of MyD88 by a Novel Inhibitor Reverses Two-Thirds of the Infarct Area in Myocardial Ischemia and Reperfusion Injury

Vγ1+γδT, Early Cardiac Infiltrated Innate Population Dominantly Producing IL-4, Protect Mice Against CVB3 Myocarditis by Modulating IFNγ+ T Response

Direct Gene Transfer with IP-10 Mutant Ameliorates Mouse CVB3-induced Myocarditis by Blunting Th1 Immune Responses.

CXCL4/CXCR3 axis regulates cardiac fibrosis by activating TGF‐β1/Smad2/3 signaling in mouse viral myocarditis

Blockade of Interleukin-17A Protects Against Coxsackievirus B3-induced Myocarditis by Increasing COX-2/PGE2 Production in the Heart.

miR-19b-3p/PKNOX1 Regulates Viral Myocarditis by Regulating Macrophage Polarization

Myeloid-derived Suppressor Cells Alleviate CVB3-induced Myocarditis Via Inducing Regulatory T Cells

Interleukin-2-inducible T-cell kinase (Itk) signaling regulates potent noncanonical regulatory T cells

The Frequency of Invariant Natural Killer T Cells Correlates with the Severity of Myocarditis.

Pathogenesis of coxsackievirus B3-induced myocarditis: role of macrophage migration inhibitory factor.

Ivermectin ameliorates acute myocarditis via the inhibition of importin-mediated nuclear translocation of NF-κB/p65

The Role of Th 17 Cells and Regulatory T Cells in Coxsackievirus B 3-Induced Myocarditis

In Vivo Delivery of Interleukin-35 Relieves Coxsackievirus-B3-induced Viral Myocarditis by Inhibiting Th17 Cells

Inhibition of Calpain Alleviates Apoptosis in Coxsackievirus B3-induced Acute Virus Myocarditis Through Suppressing Endoplasmic Reticulum Stress.

Adoptive Transfer of Regulatory T Cells Protects Against Coxsackievirus B3-Induced Cardiac Fibrosis